Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 [Yahoo! Finance]
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Mesa Laboratories (NASDAQ:MLAB) had its price target raised by analysts at Wells Fargo & Company from $75.00 to $83.00. They now have an "equal weight" rating on the stock.
Mesa Laboratories (NASDAQ:MLAB) was upgraded by analysts at Zacks Research to a "strong sell" rating.
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026